101 | 29421751 | Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway. | Chemosphere | 2018 May |
1 |
102 | 29472861 | 1,2,3,4,6-Penta-<i>O</i>-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression. | Front Pharmacol | 2018 |
1 |
103 | 30021382 | MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells. | Biomed Pharmacother | 2018 Sep |
4 |
104 | 30068546 | PTE, a novel module to target Polycomb Repressive Complex 1 to the human cyclin D2 (<i>CCND2</i>) oncogene. | J Biol Chem | 2018 Sep 14 |
2 |
105 | 30106753 | A novel hedgehog inhibitor for the treatment of hematological malignancies. | Anticancer Drugs | 2018 Nov |
1 |
106 | 30127911 | MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma. | Oncol Lett | 2018 Sep |
1 |
107 | 30193733 | Ploidy-dependent change in cyclin D2 expression and sensitization to cdk4/6 inhibition in human somatic haploid cells. | Biochem Biophys Res Commun | 2018 Sep 26 |
1 |
108 | 30308939 | Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target. | Int J Mol Sci | 2018 Oct 10 |
2 |
109 | 30357839 | LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. | J Pathol | 2019 Feb |
1 |
110 | 30776175 | Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers. | Cancer Sci | 2019 Apr |
1 |
111 | 30925453 | lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. | Mol Ther Nucleic Acids | 2019 Jun 7 |
2 |
112 | 31084542 | Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells. | J Med Food | 2019 May |
1 |
113 | 31432162 | Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth. | Mol Med Rep | 2019 Oct |
3 |
114 | 31571495 | Belinostat suppresses cell proliferation by inactivating Wnt/β-catenin pathway and promotes apoptosis through regulating PKC pathway in breast cancer. | Artif Cells Nanomed Biotechnol | 2019 Dec |
1 |
115 | 31610501 | Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells. | Environ Pollut | 2019 Dec |
1 |
116 | 32126144 | Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma. | Blood Adv | 2020 Mar 10 |
1 |
117 | 32170005 | Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility. | J Med Genet | 2020 Oct |
2 |
118 | 32184020 | Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells. | Biochem Biophys Res Commun | 2020 May 14 |
3 |
119 | 32700749 | miR‑135b‑5p enhances the sensitivity of HER‑2 positive breast cancer to trastuzumab via binding to cyclin D2. | Int J Mol Med | 2020 Oct |
3 |
120 | 32791147 | CircRSF1 contributes to endothelial cell growth, migration and tube formation under ox-LDL stress through regulating miR-758/CCND2 axis. | Life Sci | 2020 Oct 15 |
1 |
121 | 32820798 | CircTHBS1 targeting miR-211/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells. | Biosci Rep | 2021 Aug 27 |
1 |
122 | 33138842 | DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma. | Clin Epigenetics | 2020 Nov 2 |
1 |
123 | 33436648 | Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer. | Sci Rep | 2021 Jan 12 |
1 |
124 | 33480613 | Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3. | Chin Med J (Engl) | 2021 Jan 20 |
1 |
125 | 33608112 | LncRNA PRNCR1 Promotes Breast Cancer Proliferation and Inhibits Apoptosis by Modulating microRNA-377/CCND2/MEK/MAPK Axis. | Arch Med Res | 2021 Jul |
1 |
126 | 33690729 | Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line. | PLoS One | 2021 |
1 |
127 | 33764958 | Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells. | Med Sci Monit | 2021 Mar 25 |
1 |
128 | 33844344 | Circ_0093887 upregulates CCND2 and SUCNR1 to inhibit the ox-LDL-induced endothelial dysfunction in atherosclerosis by functioning as a miR-876-3p sponge. | Clin Exp Pharmacol Physiol | 2021 Aug |
2 |
129 | 34223793 | Hsa_circ_0008360 sponges miR-186-5p to target CCND2 to modulate high glucose-induced vascular endothelial dysfunction. | Cell Cycle | 2021 Jul |
3 |
130 | 34303663 | The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells. | Eur J Pharmacol | 2021 Oct 5 |
1 |
131 | 34314383 | Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1/STAT3 signaling. | Aging (Albany NY) | 2021 Jul 27 |
1 |
132 | 34746018 | LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 <i>via</i> miR-206. | Front Oncol | 2021 |
5 |
133 | 34923957 | Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway. | Cancer Cell Int | 2021 Dec 19 |
1 |
134 | 35159107 | Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo. | Cancers (Basel) | 2022 Feb 8 |
2 |
135 | 35265169 | Long Noncoding RNA LOC554202 Predicts a Poor Prognosis and Correlates with Immune Infiltration in Thyroid Cancer. | Comput Math Methods Med | 2022 |
1 |